Sucralose is a zero-calorie artificial sweetener, roughly 600 times sweeter than table sugar, sold most often under the brand name Splenda. For most people, regulators consider it safe at normal intakes (U.S. FDA), and on its own it does not raise blood sugar the way sugar does — which is exactly why it shows up in diet sodas, protein powders, and “no sugar added” foods. But “doesn’t spike glucose” and “completely inert in the body” are not the same claim, and recent research on insulin, the gut microbiome, and a sucralose by-product has added real nuance. This guide walks through what a continuous glucose monitor actually shows when you consume sucralose, where the genuine open questions are, and how to decide whether it belongs in your diet.
Does sucralose raise blood sugar?
On its own, no — and this is the part a continuous glucose monitor (CGM) makes obvious. Sucralose is not metabolized for energy; most of it passes through the body unabsorbed and is excreted, which is why it carries no calories and no carbohydrate (Roberts A et al., Food Chem Toxicol 2000, PMID 10882816). Drink sucralose-sweetened water on an empty stomach while wearing a CGM and you will typically see a flat line, not the rise-and-fall curve that a sugar-sweetened drink produces.
That makes sucralose meaningfully different from sugar. When you eat sucrose or glucose, blood sugar climbs, insulin rises to move that glucose into cells, and the level comes back down — a pattern covered in detail in Ultrahuman’s guide to the types of sugar. Sucralose skips that loop because there is no glucose to clear. For someone managing blood sugar, swapping a sugary drink for a sucralose one will usually flatten the post-drink spike.
The nuance is that “sucralose by itself” is not how most people consume it. It is almost always part of a food or eaten alongside other carbohydrates, and that context is where the research gets more interesting.
What a CGM can and can’t tell you about sucralose
A CGM is the most direct way to see how your own body responds, because the average response in a study does not always match the individual one. In published Ultrahuman M1 CGM data on non-diabetic and pre-diabetic adults, glucose responses and day-to-day variability differed measurably between people over just two weeks of monitoring (Chaudhry M et al., Sci Rep 2024, PMID 38499685). Two people can eat the same food and see different curves.
We should be upfront about one limitation. Ultrahuman’s database holds very few logged instances of sucralose consumed on its own, so the picture here draws on published research and the established principle of how a CGM reads a non-caloric sweetener, rather than on original Ultrahuman sucralose data.
For sucralose specifically, the takeaway is twofold. First, sucralose consumed alone shows little to no glucose response — because it carries no carbohydrate, there is nothing to spike. Second, what matters more is the food it replaces or accompanies. A sucralose-sweetened yogurt still contains the carbohydrate from the milk and any fruit; a “sugar-free” cookie still has flour. The sweetener isn’t spiking you, but the rest of the food can. A CGM lets you separate the two instead of assuming “sugar-free” means “glucose-flat.”
This is also why a single lab reading can be misleading. If you want to know how a specific sucralose-containing product affects you, wearing a CGM for a few days and testing it against a plain-water baseline tells you more than any general rule.
Sucralose, insulin, and the carbohydrate question
Here is where the picture stops being simple. In a controlled study, people with obesity who did not regularly use artificial sweeteners drank sucralose before an oral glucose load. Compared with water, the sucralose raised both peak blood glucose and insulin levels and lowered insulin sensitivity in that setting (Pepino MY et al., Diabetes Care 2013, PMID 23633524).
That finding doesn’t mean sucralose “spikes” you — on its own it still didn’t. It suggests that sucralose may influence how the body handles glucose that arrives with it, possibly through sweet-taste receptors in the gut that prime an insulin response. The effect has been clearest in people who don’t normally consume sweeteners, and the research is still mixed across populations. It is an open question rather than a settled harm, but it is the reason the old assumption — “zero calories, therefore zero metabolic effect” — is too clean.
In practical terms, sucralose is not a free pass to pair sweetness with refined carbohydrate and expect no metabolic consequence. The carbohydrate still counts.
What sucralose does to your gut microbiome
The most active area of research is the gut. In a randomized controlled trial in healthy adults, several non-nutritive sweeteners — including sucralose — altered the composition and function of the gut microbiome, and some of those changes tracked with measurable shifts in glucose tolerance (Suez J et al., Cell 2022, PMID 35987213). Crucially, the effects were personalized — some people responded, others barely did. This built on earlier work showing that artificial sweeteners could induce glucose intolerance through the gut microbiota in mice and a subset of humans (Suez J et al., Nature 2014, PMID 25231862).
Two honest caveats. These are short-term, controlled studies, and the glucose changes were modest and varied widely between individuals — this is not evidence that sucralose causes diabetes. But it does undercut the idea that sucralose passes through the body without interacting with anything. It interacts with the microbiome, and for some people that appears to matter.
Is sucralose safe to consume?
At normal intakes, the major regulators say yes. Sucralose has been reviewed and approved by both the U.S. FDA and the European Food Safety Authority, though the two set different acceptable daily intakes (ADIs) — 5 mg per kg of body weight per day in the U.S. (U.S. FDA, High-Intensity Sweeteners) and 15 mg/kg/day in the EU, a level EFSA reaffirmed in its 2026 re-evaluation (EFSA, 2026). Typical everyday use stays well below either threshold.
Two findings deserve mention without overstatement:
- Sucralose-6-acetate. A 2023 laboratory study reported that sucralose-6-acetate — an impurity in commercial sucralose and a compound that can form in the gut — showed signs of genotoxicity (DNA damage) in cell-based tests (Schiffman SS et al., J Toxicol Environ Health B 2023, PMID 37246822). This was an in-vitro screen, not a human-outcome study, and it has not changed regulatory status — but it is an active line of inquiry worth being aware of.
- High-heat cooking. Sucralose is not fully heat-stable, and at high baking and frying temperatures it can break down into chlorinated compounds, so it is not well suited to high-temperature cooking (Eisenreich A et al., Food Chemistry 2020, PMID 32278984). In its 2026 re-evaluation, EFSA reaffirmed sucralose’s safety at current uses but could not confirm the safety of proposed new high-temperature applications (EFSA, 2026).
So “safe” in the regulatory sense is accurate at typical intakes. “Completely studied and free of open questions” would overstate it.
Should you use sucralose?
For most people, sucralose is a reasonable tool for cutting sugar — especially as a swap that flattens the glucose spikes a sugary drink would cause. That benefit is real and visible on a CGM. The cautions are about overreliance, not acute danger.
It is worth knowing that the World Health Organization, in a 2023 guideline, advised against using non-sugar sweeteners for long-term weight control, citing a lack of evidence that they help with body fat over time and possible associations with type 2 diabetes and cardiovascular disease in observational data (WHO, 2023). That guidance is about sweeteners as a weight-loss strategy, not a safety alarm — but it reframes sucralose as a transition tool rather than an end state.
A sensible position is to use sucralose to step down from sugar if it helps, watch how specific products affect you with a CGM (especially when they’re paired with carbohydrate), and treat reducing overall sweetness — not just swapping the source — as the longer-term goal. If you already track elevated glucose outside of a diabetes diagnosis, Ultrahuman’s explainer on non-diabetic hyperglycemia is a useful next read, and the Coke Zero blood-sugar breakdown covers the diet-soda version of the same question.
This article is for informational purposes and is not medical advice. People managing diabetes, blood sugar, or any metabolic condition should work with a clinician for individual guidance. Disclosure: Ultrahuman sells the M1 CGM, Ring AIR, and Ring PRO referenced in this guide.
